Lipocine
LPCN
#9660
Rank
โ‚น5.61 B
Marketcap
โ‚น1,011
Share price
-1.15%
Change (1 day)
153.97%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: โ‚น5.61 Billion

As of January 2026 Lipocine has a market cap of โ‚น5.61 Billion. This makes Lipocine the world's 9660th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น5.61 B115.42%
2025โ‚น2.60 B19.36%
2024โ‚น2.18 B76.87%
2023โ‚น1.23 B-57.62%
2022โ‚น2.91 B-55.27%
2021โ‚น6.51 B-0.31%
2020โ‚น6.53 B532.22%
2019โ‚น1.03 B-47.69%
2018โ‚น1.97 B-57.57%
2017โ‚น4.65 B1.95%
2016โ‚น4.56 B-70.87%
2015โ‚น15.67 B267.55%
2014โ‚น4.26 B-33.94%
2013โ‚น6.45 B

End of Day market cap according to different sources

On Jan 18th, 2026 the market cap of Lipocine was reported to be:

โ‚น5.61 Billion
by Nasdaq info icon info icon
โ‚น5.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
โ‚น3.921 T 69,737.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น935.41 B 16,559.20%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
โ‚น0.94 B-83.13%๐Ÿ‡บ๐Ÿ‡ธ USA